Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382967 · ClinicalTrials.gov registry record · Phase 4
A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms
A Phase 4 study, sponsored by GE Healthcare.
- Completed
- Registry status
- Phase 4
- Development phase
- 273
- Enrollment target
NCT00382967 is a Phase 4 study that has completed, run by GE Healthcare. The registered enrollment target is 273 participants.
The verdict
NCT00382967, a Phase 4 study, has completed, sponsored by GE Healthcare.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 273 participants
- Enrollment target
Study Summary
Patients come to their doctor showing possible symptoms of a movement disorder. It is possible that these symptoms may get worse over time. There is more than one disease that can cause such symptoms. The most common movement disorder illnesses are Parkinson´s Disease and Essential Tremor. Sometimes it is difficult for doctors to make the right diagnosis because the symptoms caused by these illnesses are almost the same. On the other hand the correct treatment for Parkinson´s Disease is different from the correct treatment for Essential Tremor. This study aims to see whether having pictures of the brain taken with DaTSCAN can affect the way the doctor treats these patients and whether it can affect their quality of life directly.
Interventions
- PROCEDURE DaTSCAN SPECT imaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 273 participants |
| Start Date | 2006-10 |
| Est. Completion | 2011-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00382967
The ClinicalTrials.gov registry entry for NCT00382967 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GE Healthcare, which has 99 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which DaTSCAN SPECT imaging is the first listed.
NCT00382967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00382967 about?
NCT00382967 is a clinical study titled "A Study to Assess Changes in Clinical Management After DaTSCAN Imaging of Subjects With Clinically Uncertain Parkinsonism or an Illness With Similar Symptoms". Patients come to their doctor showing possible symptoms of a movement disorder. It is possible that these symptoms may get worse over time. There is more than one disease that can cause such symptoms. The most common movement disorder illnesses are Parkinson´s Disease and Essential Tremor. Sometimes...
What is the current status of trial NCT00382967?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 273 participants. The study started on 2006-10. Estimated completion is 2011-01.
What interventions are being tested in trial NCT00382967?
The interventions under investigation include: DaTSCAN SPECT imaging (PROCEDURE).
Who is sponsoring clinical trial NCT00382967?
This trial is sponsored by GE Healthcare, which has 99 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.